MA06.06 an Ex-Vivo Patient-Derived, Immunocompetent (PDI) Culture System to Evaluate Immunotherapeutic Agents’ Anti-Tumor Efficacy

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.362
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Development of an Ex Vivo Organ Culture Technique to Evaluate Probiotic Utilization in IBD

Journal of Clinical Gastroenterology
Gastroenterology
2016English

Quantitative Evaluation of in Vivo Target Efficacy of Anti-Tumor Agents via an Immunofluorescence and EdU Labeling Strategy

Frontiers in Pharmacology
Pharmacology
2018English

Central Nervous System Aspergillosis in an Immunocompetent Patient

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2011English

85PMechanistic Divergence of Immune Checkpoint Inhibition by an Ex Vivo Platform Derived From Patient Tumors Where Tumor and Immune Microenvironment Is Preserved

Annals of Oncology
MedicineOncologyHematology
2017English

Ex Vivo Tumor Culture Systems for Functional Drug Testing and Therapy Response Prediction

Future Science OA
MedicineBiotechnology
2017English

Evaluation of Anticancer Agents Using Patient-Derived Tumor Organoids Characteristically Similar to Source Tissues

Oncology Reports
MedicineCancer ResearchOncology
2018English

Anti-Tumor Activity of an Anti-Endoglin Monoclonal Antibody Is Enhanced in Immunocompetent Mice

International Journal of Cancer
Cancer ResearchOncology
2008English

CD38-NAD + Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2018English

Invasion of Wolbachia Into Anopheles and Other Insect Germlines in an Ex Vivo Organ Culture System

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy